(19)
(11) EP 1 185 657 A2

(12)

(88) Date of publication A3:
10.05.2001

(43) Date of publication:
13.03.2002 Bulletin 2002/11

(21) Application number: 00945801.9

(22) Date of filing: 21.06.2000
(51) International Patent Classification (IPC)7C12N 15/29, C07K 14/415, C12Q 1/68, C12N 15/82
(86) International application number:
PCT/EP0005/761
(87) International publication number:
WO 0100/801 (04.01.2001 Gazette 2001/01)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 23.06.1999 GB 9914623

(71) Applicants:
  • Syngenta Participations AG
    4058 Basel (CH)

    BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL CY 
  • Novartis-Erfindungen Verwaltungsgesellschaft m.b.H.
    1230 Wien (AT)

    AT 

(72) Inventors:
  • HABU, Yoshiki
    CH-4125 Riehen (CH)
  • MITTELSTEN SCHEID, Ortrun
    CH-4051 Basel (CH)
  • AMEDEO, Paolo,Torrey Mesa Research Institute Inc.
    San Diego, CA 92121-1125 (US)
  • PASZKOWSKI, Jerzy
    CH-4224 Nenzlingen (CH)

(74) Representative: Bastian, Werner Maria 
Syngenta Participations AG,Intellectual Property,P.O. Box
4002 Basel
4002 Basel (CH)

   


(54) GENE INVOLVED IN EPIGENETIC GENE SILENCING